首页> 外国专利> Liquid crystalline or mesogenic naphthalene derivative preparation, by reacting side-chain component with naphthalene endo-oxide derivative followed by dehydration or hydrogenation

Liquid crystalline or mesogenic naphthalene derivative preparation, by reacting side-chain component with naphthalene endo-oxide derivative followed by dehydration or hydrogenation

机译:通过使侧链组分与萘内氧化物衍生物反应,然后进行脱水或氢化,来制备液晶或介晶萘衍生物

摘要

Preparation of liquid crystalline or mesogenic naphthalene derivatives (I) involves: (a) nucleophilic addition of a compound containing a side-chain group (IV) with a naphthalene endo-oxide derivative (III), optionally in presence of a transition metal catalyst; and (b) converting the product (II) into (I) by dehydration if (II) contains a hydroxy-substituted naphthalene group or by hydrogenation if (II) contains a naphthalene endo-oxide group. Compounds (I), (II) and (III) are new. Preparation of liquid crystalline or mesogenic naphthalene derivatives of formula R1-(A1-Z1)m1-(A2-Z2)m2-W-(Z3-A3)m3-(Z4-A4)m4-R2 (I) involves: (a) nucleophilic addition of a compound containing a group of formula R1-(A1-Z1)m1-(A2-Z2)m2- (IV) with a naphthalene endo-oxide derivative of formula (III), optionally in presence of a transition metal catalyst; and (b) converting the product of formula R1-(A1-Z1)m1-(A2-Z2)m2-W-(Z3-A3)m3-(Z4-A4)m4-R2 (II) into (I) by dehydration if Q is a hydroxy-substituted naphthalene derivative group or by hydrogenation if Q is naphthalene endo-oxide derivative group. W = 1-(L1)-3-(L2)-4-(L3)-naphthalene-2,6-diyl, 1-(L1)-3-(L2)-4-(L3)-naphthalene-2,7-diyl, 1-(L1)-3-(L2)-4-(L3)-5,6,7,8-tetrahydro-naphthalene-2,6-diyl or 1-(L1)-3-(L2)-4-(L3)-5,6,7,8-tetrahydro-naphthalene-2,7-diyl; L1 - L3 = H or F; R1, R2 = H, halo, CN, NCS, SF5, 1-18C alkyl (optionally having one or two (non-adjacent) CH2 groups replaced by O, S, CO, OCO, COO, CH=CH, CF=CF and/or CC; optionally having one or more CH groups replaced by N; and optionally substituted by one or more halo and/or CN), diallylamino, dibenzylamino or benzyloxy; A1 - A4 = 1,4-cyclohexenylene or 1,4-cyclohexylene (both optionally having one or two (non-adjacent) CH2 groups replaced by O or S), 1,4-phenylene (optionally having one or two CH groups replaced by N), piperidine-1,4-diyl, 1,4-bicyclo (2.2.2) octylene, phenanthrene-2,6-diyl, naphthalene-2,6-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, 1,3-bicyclobutylene, 1,3-bicyclo (1,1,1) pentylene or spiro-(3,3)-heptane-3,6-diyl (all optionally substituted by one or more halo); Z1 - Z4 = COO, OCO, CF2O, OCF2, CH2O, OCH2, CH2CH2, (CH2)4, CH2CHMe, CH=CMe, C2F4, CH2CF2, CF2CH2, CF=CF, CF=CH, CH=CF, CH=CH, CC or a combination of two of these groups (provided that two O atoms are not directly bonded to each other); m1 - m4 = 0-2; Q = 1-(L1)-3-(L2)-4-(L3)-5-hydroxy-5,6-dihydronaphthalene-2,6-diyl, 1-(L1)-3-(L2)-4-(L3)-8-hydroxy-7,8-dihydronaphthalene-2,7-diyl or a naphthalene-endo-oxide derivative group of formula (a) or (b). Independent claims are included for the products (I) and the intermediates (III) and (II) as new compounds.
机译:液晶或介晶萘衍生物(I)的制备涉及:(a)任选地在过渡金属催化剂存在下,将含有侧链基团(IV)的化合物与萘内氧化物衍生物(III)进行亲核加成; (b)如果(II)包含羟基取代的萘基,则通过脱水将产物(II)转化为(I);或者,如果(II)包含萘内氧化物基团,则通过氢化将产物(II)转化为(I)。化合物(I),(II)和(III)是新的。式R1-(A1-Z1)m1-(A2-Z2)m2-W-(Z3-A3)m3-(Z4-A4)m4-R2的液晶或介晶萘衍生物的制备(I)涉及:(a )任选在过渡金属存在下,将含有式R1-(A1-Z1)m1-(A2-Z2)m2-(IV)的基团与式(III)的萘内氧化物衍生物进行亲核加成催化剂; (b)通过以下方式将式R1-(A1-Z1)m1-(A2-Z2)m2-W-(Z3-A3)m3-(Z4-A4)m4-R2的乘积转换为(I)如果Q是羟基取代的萘衍生物基团,则可以脱水,或者如果Q是萘基内氧化物衍生物基团,则可以氢化。 W = 1-(L1)-3-(L2)-4-(L3)-萘-2,6-二基,1-(L1)-3-(L2)-4-(L3)-萘-2, 7-二基,1-(L1)-3-(L2)-4-(L3)-5,6,7,8-四氢萘-2,6-二基或1-(L1)-3-(L2 )-4-(L3)-5,6,7,8-四氢萘-2,7-二基; L1-L3 = H或F; R1,R2 = H,卤素,CN,NCS,SF5、1-18C烷基(可选具有一个或两个(不相邻)CH2基团被O,S,CO,OCO,COO,CH = CH,CF = CF取代和/或CC;任选地具有一个或多个CH基团被N取代;并且任选地被一个或多个卤素和/或CN取代),二烯丙基氨基,二苄基氨基或苄氧基; A1-A4 = 1,4-亚环己烯基或1,4-亚环己烯(均任选被一个或两个(不相邻的)CH2基团取代为O或S),1,4-亚苯基(任选被一个或两个CH基团取代) N),哌啶-1,4-二基,1,4-双环(2.2.2)辛烯,菲-2,6-二基,萘-2,6-二基,十氢萘-2,6-二基,1 2,3,4-四氢萘-2,6-二基,1,3-双环丁烯,1,3-双环(1,1,1)戊烯基或螺-(3,3)-庚烷-3,6-二基(全部任选地被一个或多个卤素取代); Z1-Z4 = COO,OCO,CF2O,OCF2,CH2O,OCH2,CH2CH2,(CH2)4,CH2CHMe,CH = CMe,C2F4,CH2CF2,CF2CH2,CF = CF,CF = CH,CH = CF,CH = CH ,CC或这两个基团的组合(前提是两个O原子不直接键合); m1-m4 = 0-2; Q = 1-(L1)-3-(L2)-4-(L3)-5-羟基-5,6-二氢萘-2,6-二基,1-(L1)-3-(L2)-4-式(a)或(b)的(L3)-8-羟基-7,8-二氢萘-2,7-二基或萘-内氧化物衍生物基团。作为新化合物的产物(I)以及中间体(III)和(II)包括独立权利要求。

著录项

  • 公开/公告号DE10251017A1

    专利类型

  • 公开/公告日2003-05-28

    原文格式PDF

  • 申请/专利权人 MERCK PATENT GMBH;

    申请/专利号DE2002151017

  • 发明设计人 POETSCH EIKE;MEYER VOLKER;

    申请日2002-11-02

  • 分类号C07D407/02;C07C43/225;C07C15/24;C09K19/20;C07C69/76;C07C25/18;

  • 国家 DE

  • 入库时间 2022-08-21 23:41:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号